TheNote
GSK highlights key data from h... Note
GooglePlay AppStore
GSK press releases

GSK highlights key data from hepatology portfolio at the AASLD’s The Liver Meeting® 2024, emphasising patient impact in areas of high unmet need

New data shows potential for sequential therapy of bepirovirsen after daplusiran/tomligisiran to further increase functional cure rates.
https://www.gsk.com/en-gb/media/press-releases/gsk-highlights-key-data-from-hepatology-portfolio-at-the-aasld-s-the-liver-meeting-2024-emphasising-patient-impact-in-areas-of-high-unmet-need/ gsk.com
RSS Hunter RSS Hunter • Nov 13, 2024

Cookies help us deliver our Services. By using our Services or clicking I agree, you agree to our use of cookies .